Please assess the completion status of the following clinical trial:

Trial Title: Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women~* 18 years or older~* Diagnosed with stress urinary incontinence with or without urethral hypermobility~* Willing to sign informed consent~* Candidates for surgical intervention for stress incontinence~* Negative urinalysis or urine culture within 2 weeks of implantation~* Normal cystourethroscopy~* Failed at least 6 months of previous treatments for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc.)~* May have failed suspension or sling procedures~Exclusion Criteria:~* Pregnant or lactating~* Life expectancy of less than one year~* Insulin dependant diabetic~* Auto-immune disease~* Undergoing radiation therapy~* Active urinary tract infection~* Detrusor instability refractory to meds~* Reduced bladder compliance~* Significant bladder residual \>100mls~* Bladder cancer~* Unsuccessfully treated bladder stones~* Current urethral stricture preventing the passage of a 24 French endoscope~* Neurogenic bladder~* Uncorrected rectocele, cystocele, urethrocele, enterocele or pelvic prolapse of Grade 3 or higher~* Prior pelvic radiotherapy~* Artificial urinary sphincter implanted

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Experimental (Type: EXPERIMENTAL): Open Label Study, ACT (Adjustable Continence Therapy)

Based on this trial design, predict the completion outcome and termination type (if applicable).